Dr. Karen Laframboise MD, FRCPC

Education
1989 - MD, University of Ottawa 

Postgraduate Training 
1989 - 1990 - Internship, University of Manitoba
1990 - 1992 - Internal Medicine, University of Western Ontario
1992 - 1994 - Critical Care Fellowship, University of Western Ontario
1994 - 1996 - Respirology Fellowship, University of Western Ontario 

Role(s) in the Respirology Division:

• Academic Member, Division of Respirology, Critical Care and Sleep Medicine
• Respirology inpatient and outpatient care. Clinical interest and expertise is in Respirology and Critical Care Medicine. 
• Director of the Saskatchewan Pulmonary Hypertension Multidisciplinary clinic. One of only 12 recognized expert clinics in the area of Pulmonary Hypertension in Canada, the clinic has led the way in teaching and educating patients out of hospital prior to starting them on intravenous continuous prostacyclin therapy. 
• Dr. Laframboise has been actively involved in a number of research projects over the years, and has been the site Principal Investigator for a number of multicentered trials in the area of Pulmonary Hypertension, ARDS, Sepsis and COPD.

University Appointments
1997 - present - Faculty, Division of Respirology, Critical Care and Sleep Medicine, College of Medicine, University of Saskatchewan 
2001 - 2006 - Associate Professor of Medicine, College of Medicine, University of Saskatchewan
2016 - present - Clinical Associate Professor of Medicine, University of Saskatchewan 

2012 - 2014 - Internal Medicine Residency Program Committee - Assistant Program Director for Assessment and Evaluation 
2014 - present - Program Director, Core Internal Medicine Residency Program 

• Pulmonary Vascular Diseases and Pulmonary Hypertension
• General Respirology

• Cockcroft DW, Hurst T, Marciniuk D, Cotton D, Laframboise K, McNab B, Skomro R. Methacholine Challenge: Test-Shortening Procedures. CHEST. 2000;Vol 120:1857-1860.
• Cockcroft D, Hurst T, Marciniuk D, Cotton D, Laframboise K, Nagpal A, Skomro R. Routine Pulse Oximetry During Routine Methacholine Challenges is Unnecessary for Safety. CHEST. 2001;Vol 118:1378-1381.
• PausJenssen ES, Reid JK, Cockcroft DW, Laframboise KF, Ward HA. The Use of Non-invasive Ventilation in Acute Respiratory Failure at a Tertiary Care Center. CHEST. 2004;126:165-172.
• Mehat S, Helmersen D, Provencher S, Hirani N, Rubens FD, de Perrot M, Blostein K, Boutet G, Chandy C, Dennie J, Granton P, Hernandez P, Hirsch AM, Laframboise KF, Levy RD, Lien D, Martel S, Shoemaker G, Swiston J, Weinkauf J. Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline. Canadian Respiratory Journal. 2010;Volume 17(6):301-334.
• Laframboise K. Inhaled Flolan: Single Center Approach for Treatment of Pulmonary Arterial Hypertension in Non-Transplantable Patients.[abstract]. In: Respiratory Medicine. CHEST; 2012; Honolulu, HI.
• Laframboise K. Breaking News in Clinical Trials[abstract]. In: Respiratory Medicine. The Saskatchewan Thoracic Society Education Day, Saskatoon, SK; 2005 Nov 5-5.
• Carney LJ, Sheppard S, Laframboise K. The Penetration/Aspiration Risk in Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)[abstract]. In: Respiratory Medicine. CHEST; 2005 Oct 28-Nov 3.
• Krishnan B, Clemens R, Laframboise K, Nagpal A, Marciniuk D. Respiratory Mechanics with Added Deadspace (VD) During Exercise. In: Respiratory Medicine. American Journal of Respiratory and Critical Care Medicine.; 1999 Mar.
• Laframboise K, Krisnan B, Clemens R, Nagpal A, Marciniuk DD. Does the Ventilatory Response Limit Exercise Performance in the Normal Aged? Principal Investigator. In: Respiratory Medicine. American Journal of Respiratory and Critical Care Medicine.; 1999 Mar.
• Laframboise K. Canadian Asthma Guidelines – An Update[abstract]. Paper presented at: Thoracic Society Professional Education Day and Annual Meeting; 2000 Jan; Saskatoon, SK